SBCIndustrials · Consulting ServicesThe 3 Wall Street analysts covering SBC Medical Group Holdings, Inc. hold a median 12-month price target of $8.5 — +59.8% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 82 of 100 as at 3 Nov 2026 — inside the top quartile. Here, the model and the Street point the same way.
Consensus tells you what everyone already believes. The model scores SBC Medical Group Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.
Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested
Value (99): The shares cost little relative to the profits and assets behind them — which can mean the market is too gloomy, or that the business really is in trouble.
Issuance (23): The company has been issuing shares or taking on financing, diluting existing holders.
Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.
The bullish and bearish analyst opinions on SBC, reported as data — targets and ratings, the market's view beside the model's.
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
Data provided by Twelve Data
The green dot is the last close — the median target sits +59.8% from it.
| Date | Firm | Action | Rating | Target |
|---|---|---|---|---|
| 13 Aug 2026 | BTIG | Reiterates | Buy | $8.00 |
| 6 Mar 2026 | BTIG | Initiates | Buy | — |
| 6 Mar 2026 | BTIG | Initiates | Buy | $8.00 |
Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.
SBC appears in the Radar on the weeks it earns a place.
AI cloud capacity
MSFTAMZNGOOGLORCL
AI chips
NVDAAVGOAMDMU
AI networking and serversIn full
ANETDELLLITECRDO
Data centre power
VRTCEGGEVVST
Both lines are total return — dividends reinvested — so the comparison is honest on both sides.
Over the twelve months to 4 Nov 2026, SBC Medical Group Holdings, Inc. returned +62.7% against +14.8% for the S&P 500, dividends included.
Download this chart as an image — free to reuse; link this page as the source.
Data provided by Twelve Data
Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.
A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.
Cheaper than 55% of US stocks
Cheaper than 38% of US stocks
Cheaper than 42% of US stocks
Cheaper than 50% of US stocks
Higher than 60% of US stocks
Higher than 93% of US stocks
Higher than 85% of US stocks
Higher than 91% of US stocks
Higher than 87% of US stocks
Higher than 80% of US stocks
Higher than 94% of US stocks
Higher than 1% of US dividend payers
Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.
The headline figures, each with its date. Every row carries its own link — cite it straight from here.
SBC Medical Group Holdings, Inc. has a market value of $546.1M and an enterprise value of $425.8M.
Revenue in the twelve months to 30 June 2026: $175.2M. The latest quarter grew 13.4% year on year.
Net income over the same four quarters: $49.6M, a 28.3% net margin.
Diluted earnings per share, trailing twelve months: $0.47.
Free cash flow in the twelve months to 30 June 2026: $60.4M.
Trailing P/E: 11.2×; forward P/E: 9.8× — the forward figure prices analyst consensus estimates, not reported earnings.
Forward dividend yield: 0.00%, paying out 0% of earnings.
SBC Medical Group Holdings, Inc. employs 863 people — $203K of revenue per employee.
Data provided by Twelve Data
The nearest names by industry and size, scored by the same model — like for like.
Look up any of the roughly 4,600 stocks we score.
The rank is the raw material. Whether the rules would actually own SBC Medical Group Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →
SBC Medical Group Holdings announced it will release its financial results for the third quarter ended September 30, 2026, before the U.S. market opens on November 13, 2026.
Why it matters — SBC watchers can note when the company plans to report its third-quarter financial results.
SBC Medical Group Holdings announced a capital and business alliance agreement with AtomicSoftware, the Tokyo-based provider of the medicalforce clinic management platform, on October 26, 2026. The platform is used by more than 800 clinics in Japan.
Why it matters — The alliance links SBC with a clinic software provider whose platform is used across more than 800 clinics in Japan.
SBC Medical said it has begun in-house development of a DNA methylation test designed to estimate an individual's biological age. The work will be led by its subsidiary SBC AI Longevity Innovation, Inc.
Why it matters — The announcement adds a biological-age testing initiative to SBC's AI- and longevity-focused development activity.
SBC Medical Group Holdings announced it will participate in several investor conferences scheduled for October 2026. The announcement was made on September 25, 2026, through a press release from the company.
Why it matters — A SBC watcher would care because the company's participation in investor conferences signals ongoing efforts to engage with the investment community and maintain visibility.
SBC Medical Group Holdings announced it will participate in the 3rd Annual ArcStone-Kingswood Growth Summit in Toronto on September 16, 2026, at the Sheraton Center Toronto Hotel. Hikaru Fukui, Head of the IR department, will present on the company's recent milestones and future growth strategy.
Why it matters — The presentation offers SBC watchers an opportunity to hear directly from the company's IR head about its recent progress and forward-looking plans at a growth-focused investor summit.
The 3 Wall Street analysts covering SBC Medical Group Holdings, Inc. have a median 12-month price target of $8.5, with estimates ranging from $7 to $11. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.
Of the 3 analysts covering SBC Medical Group Holdings, Inc., 3 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks SBC Medical Group Holdings, Inc. 82 out of 100 across roughly 4,600 US stocks as at 3 Nov 2026. None of this is personal advice — it does not consider your circumstances.
As at 3 Nov 2026, SBC Medical Group Holdings, Inc. ranks 82 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Value (99 of 100).
No one can know that. What the data says: the median 12-month target from 3 analysts implies +59.8% from the last close, and Ticker Nerd's factor model ranks SBC Medical Group Holdings, Inc. 82 out of 100 as at 3 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.
No analyst covering SBC Medical Group Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for SBC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $7 to $11 over the next 12 months.
SBC Medical Group Holdings, Inc. returned +62.7% over the 12 months to 4 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.
SBC Medical Group Holdings Inc. is a medical services organization that provides management support and related products to cosmetic treatment centers and broader medical institutions.
The most recent item we track (GlobeNewsWire, 3 Nov 2026): "SBC Medical to Announce 3Q 2026 Financial Results". SBC Medical Group Holdings announced it will release its financial results for the third quarter ended September 30, 2026, before the U.S. market opens on November 13, 2026.
SBC Medical Group Holdings Inc. is a medical services organization that provides management support and related products to cosmetic treatment centers and broader medical institutions. Its core activities include clinic operations support, marketing, staffing, reservation management, facility coordination, construction and design assistance, procurement of medical equipment and consumables, and the licensing of medical technologies, trademarks, and brand use. The company also offers digital tools such as IT software solutions and remote consultation support, helping clinics improve day-to-day administration and patient services. SBC Medical Group Holdings Inc. operates through a network of clinics and franchisee partners across Japan and selected international markets, with services spanning aesthetic medicine, dermatology, dentistry, hair loss treatment, fertility care, ophthalmology, orthopedics, and regenerative medicine.
CEO Dr. Yoshiyuki Aikawa · 863 employees · United States · https://sbc-holdings.com
